Indian rennet

Withania coagulans · Accepted scientific name

Scientific literature: Extensive (151 studies) · ★★★★☆

Indian rennet, scientifically known as Withania coagulans, is a versatile medicinal plant native to the Indian subcontinent. Renowned for its unique coagulating properties, it is traditionally used in Ayurvedic medicine to treat various ailments. This potent herb offers significant therapeutic potential, particularly in managing inflammation and supporting overall wellness.

Family
Solanaceae
Native range
Asia-Temperate
Parts used
Fruit · Leaf
Common names
Indian Rennet · Panirband · 1 more
Scientific synonyms
Puneeria Coagulans

Names and Synonyms

Common Names

Scientific Names

Accepted name

Withania coagulans

Synonyms

Sources: Wikidata, Catalogue of Life

Taxonomical Classification

This plant belongs to the kingdom Plantae and is classified within the phylum Streptophyta and class Equisetopsida. Following the subclass Magnoliidae, it is placed under the order Solanales and the family Solanaceae. Finally, it is categorized under the genus Withania, specifically as the species Withania coagulans.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Solanales
Family Solanaceae
Genus Withania

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

This plant exhibits a wide geographical distribution spanning several key regions across Asia. In Western Asia, its presence is noted within the territories of Afghanistan and Iran. It can also be found extending into the Arabian Peninsula, specifically in Oman. Moving towards the Indian Subcontinent, the species is widely distributed throughout India. Furthermore, its range extends northward into the neighboring country of Nepal.

Region Area
Western Asia Afghanistan
Western Asia Iran
Arabian Peninsula Oman
Indian Subcontinent India
Indian Subcontinent Nepal
Indian Subcontinent Pakistan

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Ecology

The ecology of Withania coagulans is characterized by its preference for specific montane environments, where it thrives within a distinct altitudinal belt. This species is primarily distributed across mid-elevation landscapes, occupying a niche that spans from a minimum elevation of 700 m AMSL to a maximum elevation of 1300 m AMSL. Within this vertical range, the plant adapts to the varying climatic conditions and soil compositions typical of these subtropical or temperate transitional zones. Its presence is often dictated by these elevationally constrained habitats, which influence the moisture availability and temperature regimes necessary for its growth and medicinal potency.

Elevational range max:
1300 m AMSL
Elevational range min:
700 m AMSL

Life history

The life history of Withania coagulans is characterized by its classification as a chamaephyte, a growth form where the majority of the plant's regenerative buds are located close to the soil surface. Within the broader spectrum of life forms, it specifically functions as a chamaephyte, meaning its aerial parts are relatively low-growing and often protected by the ground level during unfavorable environmental conditions. This survival strategy allows the plant to persist in its natural habitats by maintaining its vital structures near the substrate, ensuring resilience against seasonal changes or herbivory. As a perennial species, its life cycle involves establishing a robust presence through these low-lying buds, which facilitate regrowth and continued development across successive growing seasons.

Life form :
chamaephyte

Morphology

The morphology of Withania coagulans is characterized by its growth habit as a woody perennial shrub, typically reaching heights of up to 60-90 cm. Structurally, the plant is not a parasite; it functions as an independent organism, meaning it lacks any obligatory or facultative parasitic relationship with host plants and relies on its own physiological processes for nutrient acquisition. The stems are characterized by a woody texture, providing a sturdy framework for its branched architecture. The leaves are simple, ovate to lanceolate in shape, and often exhibit a slightly pubescent or hairy surface. The inflorescence consists of small, greenish-yellow flowers, which eventually give rise to small, globose berries that transition in color as they mature, a hallmark of its reproductive morphology.

Parasite :
independent
Woodiness :
woody

Sources: Global Inventory of Floras and Traits (GIFT)

Plant Parts

Withania coagulans has 4 reported plant parts identified across 12 scientific publications and several other databases that are studied for medicinal purposes. The most consistently reported plant part include fruit, leaf, root, stem.

Plant parts reported in Withania coagulans
Plant part Supporting sources Consensus
Fruit 6 supporting sources ★★★☆☆
Leaf 3 supporting sources ★★☆☆☆
Root 2 supporting sources ★☆☆☆☆
Stem 1 supporting sources ★☆☆☆☆

Fruit

  1. Pakistan journal of pharmaceutical sciences
  2. Bioorganic & medicinal chemistry letters
  3. Journal of Ayub Medical College, Abbottabad : JAMC
  4. Metabolic brain disease
  5. Applied biochemistry and biotechnology
View 1 additional sources
  1. Fitoterapia

Leaf

  1. Gene
  2. Applied biochemistry and biotechnology
  3. Materials science & engineering. C, Materials for biological applications

Root

  1. Avicenna journal of phytomedicine
  2. Applied biochemistry and biotechnology

Stem

  1. Applied biochemistry and biotechnology

Chemicals

Withania coagulans has 39 reported phytochemicals identified across 12 scientific publications and several other databases. The most consistently reported chemicals include Withanolides, Withaferin A, withanolide, (17S,20S,22R)-14alpha,15alpha,17beta,20beta-tetrahydroxy-1-oxowitha-2,5,24-trienolide, 5-hydroxy tryptophan.

Chemicals reported in Withania coagulans
Chemical Supporting sources Consensus
Withanolides 8 supporting sources ★★★★☆
Withaferin A 2 supporting sources ★☆☆☆☆
withanolide 2 supporting sources ★☆☆☆☆
(17S,20S,22R)-14alpha,15alpha,17beta,20beta-tetrahydroxy-1-oxowitha-2,5,24-trienolide 1 supporting sources ★☆☆☆☆
5-hydroxy tryptophan 1 supporting sources ★☆☆☆☆
6-Benzyladenine 1 supporting sources ★☆☆☆☆
Ajugin E 1 supporting sources ★☆☆☆☆
Caryophyllene oxide 1 supporting sources ★☆☆☆☆
Coagulin E 1 supporting sources ★☆☆☆☆
Coagulin L 1 supporting sources ★☆☆☆☆

Withanolides

  1. BMC plant biology
  2. Methods in molecular biology (Clifton, N.J.)
  3. Protoplasma
  4. Pakistan journal of pharmaceutical sciences
  5. Molecules (Basel, Switzerland)
View 3 additional sources
  1. Biology
  2. Applied biochemistry and biotechnology
  3. Materials science & engineering. C, Materials for biological applications

Withaferin A

  1. Steroids
  2. Natural product communications

withanolide

  1. Zeitschrift fur Naturforschung. C, Journal of biosciences
  2. Applied biochemistry and biotechnology

(17S,20S,22R)-14alpha,15alpha,17beta,20beta-tetrahydroxy-1-oxowitha-2,5,24-trienolide

  1. Bioorganic & medicinal chemistry letters

5-hydroxy tryptophan

  1. Protoplasma

6-Benzyladenine

  1. Pakistan journal of biological sciences : PJBS

Ajugin E

  1. Biology

Caryophyllene oxide

  1. PloS one

Coagulin E

  1. Biology

Coagulin L

  1. Phytomedicine : international journal of phytotherapy and phytopharmacology

Activities

Withania coagulans has 18 reported activities identified across 12 scientific publications and several other databases. The most consistently reported activities include Antioxidant, Antihyperglycemic, Antimicrobial, Hepatoprotective, Antibacterial.

Activities reported in Withania coagulans
Activity Supporting sources Consensus
Antioxidant 4 supporting sources ★★☆☆☆
Antihyperglycemic 3 supporting sources ★★☆☆☆
Antimicrobial 3 supporting sources ★★☆☆☆
Hepatoprotective 3 supporting sources ★★☆☆☆
Antibacterial 2 supporting sources ★☆☆☆☆
Cardiovascular 2 supporting sources ★☆☆☆☆
Diuretic 2 supporting sources ★☆☆☆☆
Hypoglycemic 2 supporting sources ★☆☆☆☆
Anticancer 1 supporting sources ★☆☆☆☆
Antidepressant 1 supporting sources ★☆☆☆☆

Antioxidant

  1. Nephro-urology monthly
  2. Phytomedicine : international journal of phytotherapy and phytopharmacology
  3. PloS one
  4. RSC advances

Antihyperglycemic

  1. Nephro-urology monthly
  2. Bioorganic & medicinal chemistry letters
  3. Biology

Antimicrobial

  1. PloS one
  2. The Journal of pharmacy and pharmacology
  3. Materials science & engineering. C, Materials for biological applications

Hepatoprotective

  1. Pakistan journal of pharmaceutical sciences
  2. The Journal of pharmacy and pharmacology
  3. Biology

Antibacterial

  1. PloS one
  2. Zeitschrift fur Naturforschung. C, Journal of biosciences

Cardiovascular

  1. The Journal of pharmacy and pharmacology
  2. Biology

Diuretic

  1. Molecules (Basel, Switzerland)
  2. Biology

Hypoglycemic

  1. Journal of pharmacy & bioallied sciences
  2. Molecules (Basel, Switzerland)

Anticancer

  1. Zeitschrift fur Naturforschung. C, Journal of biosciences

Antidepressant

  1. Evidence-based complementary and alternative medicine : eCAM

Conditions

Withania coagulans has 44 reported investigations on conditions identified across 12 scientific publications and several other databases. The most consistently reported conditions include asthma, diabetes mellitus, insomnia, Antidiabetic, Benign Prostatic Hyperplasia.

Conditions investigated for Withania coagulans
Condition Supporting sources Consensus
Asthma 2 supporting sources ★☆☆☆☆
Diabetes mellitus 2 supporting sources ★☆☆☆☆
Insomnia 2 supporting sources ★☆☆☆☆
Antidiabetic 1 supporting sources ★☆☆☆☆
Benign prostatic hyperplasia 1 supporting sources ★☆☆☆☆
Diabetes mellitus 1 supporting sources ★☆☆☆☆
Escherichia coli 1 supporting sources ★☆☆☆☆
Hypercholesterolemia 1 supporting sources ★☆☆☆☆
Leishmania major 1 supporting sources ★☆☆☆☆
Parkinson's disease 1 supporting sources ★☆☆☆☆

Asthma

  1. Acta poloniae pharmaceutica
  2. Biology

Diabetes mellitus

  1. Journal of ethnopharmacology
  2. Molecules (Basel, Switzerland)

Insomnia

  1. Molecules (Basel, Switzerland)
  2. Biology

Antidiabetic

  1. ACS omega

Benign prostatic hyperplasia

  1. Nephro-urology monthly

Diabetes mellitus

  1. Journal of pharmacy & bioallied sciences

Escherichia coli

  1. PloS one

Hypercholesterolemia

  1. Pakistan journal of pharmaceutical sciences

Leishmania major

  1. Chemical & pharmaceutical bulletin

Parkinson's disease

  1. Metabolic brain disease

Preparations

Withania coagulans has 25 reported preparations identified across 12 scientific publications and several other databases. The most consistently reported preparations include crude extracts, extract, Methanolic extract, Methanolic extract of plant material, Withania Coagulans Extract (WCE).

Preparations reported for Withania coagulans
Preparation Supporting sources Consensus
Crude extracts 2 supporting sources ★☆☆☆☆
Extract 2 supporting sources ★☆☆☆☆
Methanolic extract 1 supporting sources ★☆☆☆☆
Methanolic extract of plant material 1 supporting sources ★☆☆☆☆
Withania coagulans extract (wce) 1 supporting sources ★☆☆☆☆
Withania coagulans extract 1 supporting sources ★☆☆☆☆
Aqueous extract 1 supporting sources ★☆☆☆☆
Aqueous extracts 1 supporting sources ★☆☆☆☆
Aqueous methanolic fruits (aqmfet) extracts 1 supporting sources ★☆☆☆☆
Aqueous stem extract 1 supporting sources ★☆☆☆☆

Crude extracts

  1. Evidence-based complementary and alternative medicine : eCAM
  2. Phytomedicine : international journal of phytotherapy and phytopharmacology

Extract

  1. Nephro-urology monthly
  2. Metabolic brain disease

Methanolic extract

  1. Journal of pharmacy & bioallied sciences

Methanolic extract of plant material

  1. Steroids

Withania coagulans extract (wce)

  1. Avicenna journal of phytomedicine

Withania coagulans extract

  1. Steroids

Aqueous extract

  1. ACS omega

Aqueous extracts

  1. Zeitschrift fur Naturforschung. C, Journal of biosciences

Aqueous methanolic fruits (aqmfet) extracts

  1. Pakistan journal of pharmaceutical sciences

Aqueous stem extract

  1. PloS one